Pub Date : 2023-08-01DOI: 10.1016/j.liver.2023.100168
Julia Rehsmann
Introduction
In 2012, the German transplant scandal was uncovered and reported in the national and international media. This article offers an anthropological analysis of the scandal and examines its ‘scandalous’ characteristics by taking a close look at its extraordinary and ordinary features.
Methods
The article is based on ethnographic research using multiple methods including participant observation, interviewing as well as media and document analysis.
Results
The transplant scandal in Germany revealed systemic ‘scandalous’ features of the national transplant system. From a significant lack of transparency in decision making, a weak legal framework for accountability, adherence to moralizing rules about alcohol and abstinence, to media coverage that individualized the scandal.
Conclusions
Looking at extraordinary events such as transplant scandals from an anthropological perspective offers an analysis that goes beyond the singular, scandalous event. An anthropological analysis allows to highlight the ordinary and ambivalent ‘scandalous’ features of transplant medicine It examines transplant medicine at the intersection of biomedicine, politics, and morality.
{"title":"A revealing scandal: The German transplant scandal between structural failures, moralizing rules, and ambivalent manipulations","authors":"Julia Rehsmann","doi":"10.1016/j.liver.2023.100168","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100168","url":null,"abstract":"<div><h3>Introduction</h3><p>In 2012, the German transplant scandal was uncovered and reported in the national and international media. This article offers an anthropological analysis of the scandal and examines its ‘scandalous’ characteristics by taking a close look at its extraordinary and ordinary features.</p></div><div><h3>Methods</h3><p>The article is based on ethnographic research using multiple methods including participant observation, interviewing as well as media and document analysis.</p></div><div><h3>Results</h3><p>The transplant scandal in Germany revealed systemic ‘scandalous’ features of the national transplant system. From a significant lack of transparency in decision making, a weak legal framework for accountability, adherence to moralizing rules about alcohol and abstinence, to media coverage that individualized the scandal.</p></div><div><h3>Conclusions</h3><p>Looking at extraordinary events such as transplant scandals from an anthropological perspective offers an analysis that goes beyond the singular, scandalous event. An anthropological analysis allows to highlight the ordinary and ambivalent ‘scandalous’ features of transplant medicine It examines transplant medicine at the intersection of biomedicine, politics, and morality.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100168"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49881982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1016/j.liver.2023.100159
Ariana Chirban , Anushi Shah , Taylor M Coe , Heidi Yeh , Jennie Galpern , Jessica Witchey , Lorraine Castaldo , Nahel Elias , Angela Fitch , Leigh Anne Dageforde
Introduction
Obesity-associated comorbidities increase risks for patients undergoing liver transplant. In this study, we explore patient perspectives and motivation for healthy weight management among patients on the liver transplant waiting list.
Methods
This is a cross-sectional, observational, electronic survey-based study. A survey on weight management was administered to patients on the liver transplant waiting list. Demographic and clinical data were collected from patients’ medical records. Data was analyzed using Pearson's chi-squared, Fisher's exact, and Student's t-tests.
Results
Respondents had a mean age of 54.4 years, were predominately male (62.0%) with a mean BMI of 29.2 kg/m2 with alcoholic cirrhosis as the leading etiology of liver disease (33.9%). Among patients with a BMI≥30 kg/m2, 59.0% perceived that they were overweight and 23.1% believed they were underweight. Among patients with BMI≥30 kg/m2 who perceived they were overweight, 39.1% were actively trying to lose weight and 60.9% were trying to keep from gaining weight. Regardless of current weight, there was a median increase in BMI for patients who categorized themselves as having lost weight or maintained weight since being waitlisted.
Conclusion
Many patients with a BMI≥30 kg/m2 did not perceive themselves as overweight and were not actively trying to lose weight. Weight perception was not consistent with actual weight change while waitlisted for liver transplant. Further research is needed to understand how weight awareness and weight perception impacts motivation for weight loss.
{"title":"Understanding the patient perspective of weight management while on the liver transplant waitlist","authors":"Ariana Chirban , Anushi Shah , Taylor M Coe , Heidi Yeh , Jennie Galpern , Jessica Witchey , Lorraine Castaldo , Nahel Elias , Angela Fitch , Leigh Anne Dageforde","doi":"10.1016/j.liver.2023.100159","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100159","url":null,"abstract":"<div><h3>Introduction</h3><p>Obesity-associated comorbidities increase risks for patients undergoing liver transplant. In this study, we explore patient perspectives and motivation for healthy weight management among patients on the liver transplant waiting list.</p></div><div><h3>Methods</h3><p>This is a cross-sectional, observational, electronic survey-based study. A survey on weight management was administered to patients on the liver transplant waiting list. Demographic and clinical data were collected from patients’ medical records. Data was analyzed using Pearson's chi-squared, Fisher's exact, and Student's t-tests.</p></div><div><h3>Results</h3><p>Respondents had a mean age of 54.4 years, were predominately male (62.0%) with a mean BMI of 29.2 kg/m<sup>2</sup> with alcoholic cirrhosis as the leading etiology of liver disease (33.9%). Among patients with a BMI≥30 kg/m<sup>2</sup>, 59.0% perceived that they were overweight and 23.1% believed they were underweight. Among patients with BMI≥30 kg/m<sup>2</sup> who perceived they were overweight, 39.1% were actively trying to lose weight and 60.9% were trying to keep from gaining weight. Regardless of current weight, there was a median increase in BMI for patients who categorized themselves as having lost weight or maintained weight since being waitlisted.</p></div><div><h3>Conclusion</h3><p>Many patients with a BMI≥30 kg/m<sup>2</sup> did not perceive themselves as overweight and were not actively trying to lose weight. Weight perception was not consistent with actual weight change while waitlisted for liver transplant. Further research is needed to understand how weight awareness and weight perception impacts motivation for weight loss.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100159"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1016/j.liver.2023.100156
Giorgio Della Rocca , Alessandra Della Rocca
In patients undergoing orthotopic liver transplantation (OLTx) surgery, the intraoperative hemodynamic monitoring technique that is most utilized is still the pulmonary artery catheter (PAC). The popularity of transesophageal echocardiography (TEE) is increasing, so today's updated issue is the following: should the use of PAC and/or volumetric monitoring with transpulmonary thermodilution and/or advanced volumetric PAC be limited in clinical practice, only for some high risk patients? Could we use the TEE, if necessary, in less critical ill patients undergoing OLTx surgery?
We can integrate all of the aforementioned monitoring techniques in an increasing modular step wise monitoring concept. But in an uncertain hemodynamic situation, transthoracic and/or transoesophageal echocardiographic evaluation represents a cornerstone.
The use of echocardiography during OLTx is more and more common with several benefits demonstrated particularly by the TEE in this patient population.
To achieve and maintain adequate tissue perfusion becomes difficult in case of major bleeding, an event quite possible to occur during OLTx, affecting the immediate and the late outcome.
All the clinicians agree that bleeding interfere with the choice of hemodynamic monitoring and or vice versa.
A reasonable compromise is to find a balance between the need to extend monitoring in high-risk surgical patients and the average consumption of blood products that characterizes each individual transplant center. This is also in line with what is shown in literature in terms of Maximum Surgical Blood Ordering Schedule (MSBOS).
{"title":"Hemodynamic monitoring in liver Transplantation patients in the third millennium","authors":"Giorgio Della Rocca , Alessandra Della Rocca","doi":"10.1016/j.liver.2023.100156","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100156","url":null,"abstract":"<div><p>In patients undergoing orthotopic liver transplantation (OLTx) surgery, the intraoperative hemodynamic monitoring technique that is most utilized is still the pulmonary artery catheter (PAC). The popularity of transesophageal echocardiography (TEE) is increasing, so today's updated issue is the following: should the use of PAC and/or volumetric monitoring with transpulmonary thermodilution and/or advanced volumetric PAC be limited in clinical practice, only for some high risk patients? Could we use the TEE, if necessary, in less critical ill patients undergoing OLTx surgery?</p><p>We can integrate all of the aforementioned monitoring techniques in an increasing modular step wise monitoring concept. But in an uncertain hemodynamic situation, transthoracic and/or transoesophageal echocardiographic evaluation represents a cornerstone.</p><p>The use of echocardiography during OLTx is more and more common with several benefits demonstrated particularly by the TEE in this patient population.</p><p>To achieve and maintain adequate tissue perfusion becomes difficult in case of major bleeding, an event quite possible to occur during OLTx, affecting the immediate and the late outcome.</p><p>All the clinicians agree that bleeding interfere with the choice of hemodynamic monitoring and or vice versa.</p><p>A reasonable compromise is to find a balance between the need to extend monitoring in high-risk surgical patients and the average consumption of blood products that characterizes each individual transplant center. This is also in line with what is shown in literature in terms of Maximum Surgical Blood Ordering Schedule (MSBOS).</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100156"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1016/j.liver.2023.100158
Annu Sarin Jolly, Vidyadhar Metri, Sanjay K. Goja, Nandini Dave, Ashok Thorat, Vaibhav, Manoj Singh
Portopulmonary hypertension (PoPH) is a rare but serious disorder carrying a very poor prognosis. PoPH is defined as the presence of pulmonary arterial hypertension (PAH) associated with portal hypertension, with or without underlying liver disease. We are reporting our institutional experience of anaesthetic management of an 8-year old female child weighing 20 kg with severe PoPH who underwent liver transplantation (LT). The use of pulmonary vasodilators in the perioperative period along with a carefully planned anaesthetic strategy was critical in the successful outcome of this potentially lethal disorder.
{"title":"Perioperative management of severe portopulmonary hypertension in a paediatric living donor liver transplantation using pulmonary vasodilators","authors":"Annu Sarin Jolly, Vidyadhar Metri, Sanjay K. Goja, Nandini Dave, Ashok Thorat, Vaibhav, Manoj Singh","doi":"10.1016/j.liver.2023.100158","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100158","url":null,"abstract":"<div><p>Portopulmonary hypertension (PoPH) is a rare but serious disorder carrying a very poor prognosis. PoPH is defined as the presence of pulmonary arterial hypertension (PAH) associated with portal hypertension, with or without underlying liver disease. We are reporting our institutional experience of anaesthetic management of an 8-year old female child weighing 20 kg with severe PoPH who underwent liver transplantation (LT). The use of pulmonary vasodilators in the perioperative period along with a carefully planned anaesthetic strategy was critical in the successful outcome of this potentially lethal disorder.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100158"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1016/j.liver.2023.100165
Sophia EL Boukili, Laurent Reydellet, Valery Blasco, Karim Harti, Jacques Albanese, Cyril Nafati
Purpose
Cirrhotic cardiomyopathy (CCM) is a major comorbidity of cirrhosis. The diagnostic performance of conventional echocardiography is poor. Two-dimensional-strain echo-cardiography (2D-strain) detects myocardial dysfunction earlier than conventional echocardiography, with a significant prognostic value. The aim of our study is to assess whether the 2D-strain will allow a more relevant assessment of CCM in cirrhotic patients than conventional echocardiography. The secondary objective is to determine if altered strain or strain rate are associated with cirrhotic patient's outcome in intensive care unit (ICU).
Methods
Conventional echocardiography and 2D-strain were performed on 44 consecutive patients within 24 hours of admission to the ICU. Using 2D-strain, the global-longitudinal-strain (GLS) was assessed.
Results
GLS was impaired in 64% of patients. GLS was significantly higher in the patients who died compared with those who survived, using 28-day mortality rate (-17 vs -14 p < 0.039). Regarding conventional echocardiography, no factor was associated with increased mortality.
Conclusion
GLS is correlated to cirrhotic patient's prognosis in intensive care, while conventional echocardiography shows no dysfunction.
目的肝硬化性心肌病(CCM)是肝硬化的主要合并症。常规超声心动图的诊断性能较差。二维应变超声心动图(2D-strain)比常规超声心动图更早发现心肌功能障碍,具有重要的预后价值。我们研究的目的是评估2D-strain是否能够比传统超声心动图更相关地评估肝硬化患者的CCM。次要目的是确定应变或应变率的改变是否与肝硬化患者在重症监护病房(ICU)的预后有关。方法对44例连续入院24小时的患者行常规超声心动图和二维应变检查。采用2d -应变法对全局-纵向-应变(GLS)进行评估。结果64%的患者gls功能受损。使用28天死亡率计算,死亡患者的GLS明显高于存活患者(-17 vs -14 p <0.039)。对于常规超声心动图,没有任何因素与死亡率增加相关。结论ls与肝硬化重症监护患者预后相关,而常规超声心动图显示无功能障碍。
{"title":"Prognostic value of two-dimensional strain-echocardiography in patients with liver cirrhosis in Intensive care Unit. A prospective, observational Study","authors":"Sophia EL Boukili, Laurent Reydellet, Valery Blasco, Karim Harti, Jacques Albanese, Cyril Nafati","doi":"10.1016/j.liver.2023.100165","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100165","url":null,"abstract":"<div><h3>Purpose</h3><p>Cirrhotic cardiomyopathy (CCM) is a major comorbidity of cirrhosis. The diagnostic performance of conventional echocardiography is poor. Two-dimensional-strain echo-cardiography (2D-strain) detects myocardial dysfunction earlier than conventional echocardiography, with a significant prognostic value. The aim of our study is to assess whether the 2D-strain will allow a more relevant assessment of CCM in cirrhotic patients than conventional echocardiography. The secondary objective is to determine if altered strain or strain rate are associated with cirrhotic patient's outcome in intensive care unit (ICU).</p></div><div><h3>Methods</h3><p>Conventional echocardiography and 2D-strain were performed on 44 consecutive patients within 24 hours of admission to the ICU. Using 2D-strain, the global-longitudinal-strain (GLS) was assessed.</p></div><div><h3>Results</h3><p>GLS was impaired in 64% of patients. GLS was significantly higher in the patients who died compared with those who survived, using 28-day mortality rate (-17 vs -14 <em>p <</em> 0.039). Regarding conventional echocardiography, no factor was associated with increased mortality.</p></div><div><h3>Conclusion</h3><p>GLS is correlated to cirrhotic patient's prognosis in intensive care, while conventional echocardiography shows no dysfunction.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100165"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49881979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1016/j.liver.2023.100157
Z. Tremblay , A. Kawaguchi , A. Calderone , M. Beaunoyer , F. Alvarez , M. Lallier , P. Jouvet
Background
Pediatric liver transplantation is performed with either whole, reduced, split livers depending on the technical aspects of the surgery and the discrepancy between donor and recipient body dimensions. The optimal method of partial hepatectomy for pediatric transplants remains debated to this day: either in situ (i.e. occurring before liver removal from the donor) or ex situ (i.e. taking place after liver removal). In 2007, our tertiary academic center changed its surgical protocol from ex situ to in situ partial hepatectomy in deceased donor mainly to decrease bleeding complication risk among other amendments. Our study aimed to evaluate the clinical impact of this major modification on the post-operative blood products volume transfusion.
Methods
A retrospective analysis of 104 patients who underwent liver transplantation at our pediatric center between 1998 and 2016 was performed. Patients receiving multiple organ transplantations or re-transplantation were excluded from the study. Differences in blood products transfusion volume, post-operative complications and mortality rates were compared between two periods implementing different surgical transplantation protocols: ex situ partial hepatectomy from 1998 to 2006 and in situ partial hepatectomy from 2007 to 2016.
Results
42 children from the original ex situ protocol group and 62 children from the modified in situ protocol group were included in the study. The median age and weight were 1.5 years (0.7–4.8 kg) and 11.1 kg (7.9–18.2), respectively. There were no significant differences in demographic data between groups. A significant decrease in liver transplant cold ischemia time was observed in the in situ group compared to the ex situ group (p < 0.001). A significant increase in vasopressor use was observed for the in situ group (64% (IS) vs. 24% ex situ group (p < 0.001)), as part of the protocol modifications. Median perioperative blood products transfusion volume was not significantly different between both groups: 275 ml/kg (76–497) ex situ group vs. 229 ml/kg (76–499) in situ group (p = 0.82). We observed a 28-day and 90-day mortality rate of 14.3% and 16.6%, respectively, for the ex situ group and 6.5% and 8.1%, respectively, for the in situ group. Hepatic artery thrombosis was found in the first 7 days in 7% of the ex situ group patients and 6% of the in situ group patients. There were no significant differences in post-operative mortality and morbidity rates observed between groups (p value of 0.29 and 0.28 for 28-days and 90-days mortality rates, respectively).
Conclusions
Although the median amount of transfusion was higher in the ex-situ group, our stud
{"title":"Impacts of in situ donor partial hepatectomy in pediatric liver transplantation","authors":"Z. Tremblay , A. Kawaguchi , A. Calderone , M. Beaunoyer , F. Alvarez , M. Lallier , P. Jouvet","doi":"10.1016/j.liver.2023.100157","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100157","url":null,"abstract":"<div><h3>Background</h3><p>Pediatric liver transplantation is performed with either whole, reduced, split livers depending on the technical aspects of the surgery and the discrepancy between donor and recipient body dimensions. The optimal method of partial hepatectomy for pediatric transplants remains debated to this day: either <em>in situ</em> (<em>i.e.</em> occurring before liver removal from the donor) or <em>ex situ</em> (<em>i.e.</em> taking place after liver removal). In 2007, our tertiary academic center changed its surgical protocol from <em>ex situ</em> to <em>in situ</em> partial hepatectomy in deceased donor mainly to decrease bleeding complication risk among other amendments. Our study aimed to evaluate the clinical impact of this major modification on the post-operative blood products volume transfusion.</p></div><div><h3>Methods</h3><p>A retrospective analysis of 104 patients who underwent liver transplantation at our pediatric center between 1998 and 2016 was performed. Patients receiving multiple organ transplantations or re-transplantation were excluded from the study. Differences in blood products transfusion volume, post-operative complications and mortality rates were compared between two periods implementing different surgical transplantation protocols: <em>ex situ</em> partial hepatectomy from 1998 to 2006 and <em>in situ</em> partial hepatectomy from 2007 to 2016.</p></div><div><h3>Results</h3><p>42 children from the original <em>ex situ</em> protocol group and 62 children from the modified <em>in situ</em> protocol group were included in the study. The median age and weight were 1.5 years (0.7–4.8 kg) and 11.1 kg (7.9–18.2), respectively. There were no significant differences in demographic data between groups. A significant decrease in liver transplant cold ischemia time was observed in the <em>in situ</em> group compared to the <em>ex situ</em> group (<em>p</em> < 0.001). A significant increase in vasopressor use was observed for the <em>in situ</em> group (64% (IS) <em>vs</em>. 24% <em>ex situ</em> group (<em>p</em> < 0.001)), as part of the protocol modifications. Median perioperative blood products transfusion volume was not significantly different between both groups: 275 ml/kg (76–497) <em>ex situ</em> group <em>vs</em>. 229 ml/kg (76–499) <em>in situ</em> group (<em>p</em> = 0.82). We observed a 28-day and 90-day mortality rate of 14.3% and 16.6%, respectively, for the <em>ex situ</em> group and 6.5% and 8.1%, respectively, for the <em>in situ</em> group. Hepatic artery thrombosis was found in the first 7 days in 7% of the <em>ex situ</em> group patients and 6% of the <em>in situ</em> group patients. There were no significant differences in post-operative mortality and morbidity rates observed between groups (p value of 0.29 and 0.28 for 28-days and 90-days mortality rates, respectively).</p></div><div><h3>Conclusions</h3><p>Although the median amount of transfusion was higher in the ex-situ group, our stud","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100157"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1016/j.liver.2023.100160
James Neuberger
{"title":"Liver transplant registries: Need, benefits and risks","authors":"James Neuberger","doi":"10.1016/j.liver.2023.100160","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100160","url":null,"abstract":"","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100160"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1016/j.liver.2023.100167
Julie Gaudefroy , Paul Brunet , Baptiste Lordier , Benjamin Lebas , Julien Pottecher
Acute on Chronic Liver Failure (ACLF) is a severe condition that can be seen in all patients with liver disease and is associated with high short-term mortality. Decompensated cirrhosis and organ failures resulting can lead to an admission in Intensive Care Unit (ICU) where only few tools can be used to evaluate the safety or futility of care, including liver transplantation. High short-term mortality for patients with ACLF admitted in ICU is a reason to ethically propose a liver transplantation as a curative treatment despite the existence of multi-organ failures. However, caution is advised for patients with grade-3 ACLF as they have to be attentively selected by a multidisciplinary approach, carefully evaluated and may benefit from an early transplant with a low-risk donor graft. Recent use of perfusion machine to increase outcomes after liver transplant in these urgent situations still needs to be evaluated. This review summarizes the ACLF entity and presents some recommendations about liver transplantation (LT) candidates in terms of selection, evaluation and timing of LT.
{"title":"Assessment of liver transplantation eligibility for ACLF patients","authors":"Julie Gaudefroy , Paul Brunet , Baptiste Lordier , Benjamin Lebas , Julien Pottecher","doi":"10.1016/j.liver.2023.100167","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100167","url":null,"abstract":"<div><p>Acute on Chronic Liver Failure (ACLF) is a severe condition that can be seen in all patients with liver disease and is associated with high short-term mortality. Decompensated cirrhosis and organ failures resulting can lead to an admission in Intensive Care Unit (ICU) where only few tools can be used to evaluate the safety or futility of care, including liver transplantation. High short-term mortality for patients with ACLF admitted in ICU is a reason to ethically propose a liver transplantation as a curative treatment despite the existence of multi-organ failures. However, caution is advised for patients with grade-3 ACLF as they have to be attentively selected by a multidisciplinary approach, carefully evaluated and may benefit from an early transplant with a low-risk donor graft. Recent use of perfusion machine to increase outcomes after liver transplant in these urgent situations still needs to be evaluated. This review summarizes the ACLF entity and presents some recommendations about liver transplantation (LT) candidates in terms of selection, evaluation and timing of LT.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100167"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-20DOI: 10.1016/j.liver.2023.100169
Gabriel Wisenfeld Paine , Michael Toolan , Jeremy S Nayagam , Deepak Joshi , Brian J Hogan , Colm McCabe , Philip Marino , Sameer Patel
Portopulmonary hypertension (PoPH) is defined as the presence of otherwise unexplained pre-capillary pulmonary hypertension in patients with portal hypertension of cirrhotic or non-cirrhotic aetiology. PoPH occurs in at least 5–8.5% of patients being worked up for a liver transplant (LT) and its prevalence is thought to be increasing. Uncontrolled PoPH prior to LT is associated with high perioperative morbidity and mortality, with severe PoPH being considered a contraindication to LT. Early recognition and appropriate management of PoPH in patients being considered for LT is therefore imperative to achieve optimal outcomes. This review provides a detailed overview of: the epidemiology, prognosis and pathophysiology of PoPH; clinical assessment, screening and diagnostic approach; and pre-, peri‑ and post-transplant management of PoPH in patients undergoing LT. The current evidence base in this area is limited. This review particularly focuses on the evidence both supporting and challenging current practices and highlights areas for future research.
{"title":"Assessment and management of patients with portopulmonary hypertension undergoing liver transplantation","authors":"Gabriel Wisenfeld Paine , Michael Toolan , Jeremy S Nayagam , Deepak Joshi , Brian J Hogan , Colm McCabe , Philip Marino , Sameer Patel","doi":"10.1016/j.liver.2023.100169","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100169","url":null,"abstract":"<div><p>Portopulmonary hypertension (PoPH) is defined as the presence of otherwise unexplained pre-capillary pulmonary hypertension in patients with portal hypertension of cirrhotic or non-cirrhotic aetiology. PoPH occurs in at least 5–8.5% of patients being worked up for a liver transplant (LT) and its prevalence is thought to be increasing. Uncontrolled PoPH prior to LT is associated with high perioperative morbidity and mortality, with severe PoPH being considered a contraindication to LT. Early recognition and appropriate management of PoPH in patients being considered for LT is therefore imperative to achieve optimal outcomes. This review provides a detailed overview of: the epidemiology, prognosis and pathophysiology of PoPH; clinical assessment, screening and diagnostic approach; and pre-, peri‑ and post-transplant management of PoPH in patients undergoing LT. The current evidence base in this area is limited. This review particularly focuses on the evidence both supporting and challenging current practices and highlights areas for future research.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"12 ","pages":"Article 100169"},"PeriodicalIF":0.0,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50203521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-01DOI: 10.1016/j.liver.2023.100153
Manuel Lozano , Miguel Molina , Jesús Zarauza , Federico Castillo , Roberto Fernández-Santiago , Edward J. Anderson , Emilio Fábrega , Juan C. Rodríguez-Sanjuán
Cardiovascular events are the most important cause of morbidity and mortality after liver transplant (LT), since many recipients are older with cardiovascular risk factors and pathophysiology particular to end stage liver disease. Moreover, the LT procedure is associated with a unique cardiac risk. Detection of cardiovascular disease and stratification of risk have, therefore, an important impact on the prognosis of these patients.
{"title":"Cardiovascular assessment of candidates for liver transplant","authors":"Manuel Lozano , Miguel Molina , Jesús Zarauza , Federico Castillo , Roberto Fernández-Santiago , Edward J. Anderson , Emilio Fábrega , Juan C. Rodríguez-Sanjuán","doi":"10.1016/j.liver.2023.100153","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100153","url":null,"abstract":"<div><p>Cardiovascular events are the most important cause of morbidity and mortality after liver transplant (LT), since many recipients are older with cardiovascular risk factors and pathophysiology particular to end stage liver disease. Moreover, the LT procedure is associated with a unique cardiac risk. Detection of cardiovascular disease and stratification of risk have, therefore, an important impact on the prognosis of these patients.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"10 ","pages":"Article 100153"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49880130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}